Perioperative Sepsis. An Epigenetic Perspective

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCarol Davila University of Medicine and Pharmacy

About this trial

This single-center, prospective, observational study evaluates the impact of perioperative sepsis on inflammatory response, coagulation abnormalities, cardiac dysfunction, and microRNA expression in adult patients undergoing major abdominal surgery. Forty patients are enrolled and classified into septic and non-septic groups according to international sepsis definitions based on SOFA score criteria. Clinical, biochemical, echocardiographic, and molecular parameters, including selected microRNAs, are assessed preoperatively and within the first 24 hours postoperatively. The study aims to characterize pathophysiological differences associated with perioperative sepsis and to explore the potential prognostic value of microRNAs as early biomarkers of postoperative sepsis.

Eligibility criteria

Qualifiers

Age ≥18 years

Undergoing major abdominal surgery (elective or emergency)

Ability to provide written informed consent

Availability of biological samples in the preoperative period and within 24 hours postoperatively

Disqualifiers

Surgical reintervention within 3 months after the index procedure

Multiple surgical procedures during the same hospitalization

Active chronic infections (HIV, active viral hepatitis, tuberculosis)

Autoimmune or systemic inflammatory diseases

Trial design

Treatments tested in this trial

  • • Presepsin • C-reactive protein (CRP) • Fibrinogen • Aspartate aminotransferase (AST) • Alanine aminotransferase (ALT) • Creatinine • Urea • Creatine kinase (CK) • Creatine kinase-MB (CK-MB) • NT-pro

Treatment groups

40 Participants
are divided into 2 treatment groups